161 related articles for article (PubMed ID: 37548271)
1. Constitutional balanced translocations involving SMARCB1: A rare cause of rhabdoid tumor predisposition syndrome.
Blackburn PR; McGee RB; Mostafavi R; Carroll AJ; Mikhail FM; Armstrong GT; Furtado LV; Chiang J; Wheeler DA; Carey SS; Nichols KE; Upadhyaya SA
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23195. PubMed ID: 37548271
[TBL] [Abstract][Full Text] [Related]
2. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
[TBL] [Abstract][Full Text] [Related]
3. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.
Frühwald MC; Nemes K; Boztug H; Cornips MCA; Evans DG; Farah R; Glentis S; Jorgensen M; Katsibardi K; Hirsch S; Jahnukainen K; Kventsel I; Kerl K; Kratz CP; Pajtler KW; Kordes U; Ridola V; Stutz E; Bourdeaut F
Fam Cancer; 2021 Oct; 20(4):305-316. PubMed ID: 33532948
[TBL] [Abstract][Full Text] [Related]
4. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
[TBL] [Abstract][Full Text] [Related]
5. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
6. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
7. Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors.
Sabatella M; Mantere T; Waanders E; Neveling K; Mensenkamp AR; van Dijk F; Hehir-Kwa JY; Derks R; Kwint M; O'Gorman L; Tropa Martins M; Gidding CE; Lequin MH; Küsters B; Wesseling P; Nelen M; Biegel JA; Hoischen A; Jongmans MC; Kuiper RP
J Pathol; 2021 Oct; 255(2):202-211. PubMed ID: 34231212
[TBL] [Abstract][Full Text] [Related]
8. Atypical Teratoid/Rhabdoid Sellar Tumor in an Adult with a Familial History of a Germline SMARCB1 Mutation: Case Report and Review of the Literature.
Voisin MR; Ovenden C; Tsang DS; Gupta AA; Huang A; Gao AF; Diamandis P; Almeida JP; Gentili F
World Neurosurg; 2019 Jul; 127():336-345. PubMed ID: 31004861
[TBL] [Abstract][Full Text] [Related]
9. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract][Full Text] [Related]
10. Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation.
Metts JL; Park SI; Soares BP; Fong C; Biegel JA; Goldsmith KC
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28111898
[TBL] [Abstract][Full Text] [Related]
11. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
[TBL] [Abstract][Full Text] [Related]
12. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
[TBL] [Abstract][Full Text] [Related]
13. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors.
Shirai R; Osumi T; Terashima K; Kiyotani C; Uchiyama M; Tsujimoto S; Yoshida M; Yoshida K; Uchiyama T; Tomizawa D; Shioda Y; Sekiguchi M; Watanabe K; Keino D; Ueno-Yokohata H; Ohki K; Takita J; Ito S; Deguchi T; Kiyokawa N; Ogiwara H; Hishiki T; Ogawa S; Okita H; Matsumoto K; Yoshioka T; Kato M
Eur J Hum Genet; 2020 Aug; 28(8):1124-1128. PubMed ID: 32218533
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
17. Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.
Modena P; Sardi I; Brenca M; Giunti L; Buccoliero AM; Pollo B; Biassoni V; Genitori L; Antonelli M; Maestro R; Giangaspero F; Massimino M
BMC Cancer; 2013 Mar; 13():100. PubMed ID: 23510391
[TBL] [Abstract][Full Text] [Related]
18. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
[TBL] [Abstract][Full Text] [Related]
19. Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor.
Tauziède-Espariat A; Masliah-Planchon J; Brugières L; Puget S; Dufour C; Schneider P; Laquerrière A; Frebourg T; Bodet D; Lechapt-Zalcman E; Pierron G; Delattre O; Varlet P; Bourdeaut F
Eur J Hum Genet; 2017 Oct; 25(10):1170-1172. PubMed ID: 28722703
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]